Cafepharma Today

November 20 2024 - Novo, Viking heat up MASH space with promising data at AASLD24
Novo, Viking heat up MASH space with promising data at AASLD24
Pfizer, under pressure to change, names oncology head as new R&D chief
What might a Trump administration mean for the Biosecure Act?
Sage wilts as Huntington's prospect flunks trial
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

FDA wants clear drug labels
Allentown Morning Call, PA
Saturday, August 23, 2008 - 10:37am
tags:
Owning Abbott shares a 'badge of honor'
Waukegan News Sun, IL
Saturday, August 23, 2008 - 10:35am
tags:
Cymbalta Receives European Approval For The Treatment Of Generalised Anxiety Disorder
Medical News Today
Saturday, August 23, 2008 - 10:32am
tags:
Indevus Pharmaceuticals Announces Completion Of Enrollment In Phase III Trial Of PRO 2000
Medical News Today
Saturday, August 23, 2008 - 10:32am
tags:
FDA Needs Nine More Months to Study Vytorin, Cancer Link
MedHeadlines
Saturday, August 23, 2008 - 10:30am
tags:
Health Winners & Losers: Alpharma
Yahoo/TheStreet.com
Friday, August 22, 2008 - 7:23pm
tags:
BioMarin Pharmaceutical shares rise on long-term outlook for genetic disorder treatment
Yahoo/AP
Friday, August 22, 2008 - 7:22pm
tags:
FDA rule on drug labeling attracts praise from drugmakers, ire from lawyers
Yahoo/AP
Friday, August 22, 2008 - 7:21pm
tags:
Pharma Deals: Start Hostile. Get Friendly.
WSJ Online
Friday, August 22, 2008 - 7:20pm
tags:
King Pharma raises pressure on rival
Financial Times
Friday, August 22, 2008 - 7:19pm
tags:
Abbott Tries a Crash Diet
Motley Fool
Friday, August 22, 2008 - 4:27pm
tags:
Amgen's Nplate Approved by U.S. for Bleeding Disorder
Bloomberg
Friday, August 22, 2008 - 3:18pm
tags:
Alpharma shares surge on King buyout offer
Forbes
Friday, August 22, 2008 - 3:17pm
tags:
Genentech Ditches Stock Options to Fund $371 Million Retention Plan
WSJ Online
Friday, August 22, 2008 - 10:02am
tags:
Merger Watch: APP Pharmaceuticals - Fresenius
Seeking Alpha
Friday, August 22, 2008 - 10:01am
tags:
Onyx and Bayer say patients are enrolling in trial of Nexavar for liver cancer
Yahoo/AP
Friday, August 22, 2008 - 9:39am
tags:
Eli Lilly's Cymbalta gets expanded European approval as anxiety disorder treatment
Yahoo/AP
Friday, August 22, 2008 - 9:36am
tags:
Fresenius Stays Strong in Tough Times
Businessweek
Friday, August 22, 2008 - 9:34am
tags:
FDA: Vytorin Not Linked to Cancer Risk
WSJ Online
Friday, August 22, 2008 - 9:33am
tags:
King Pharmaceuticals Bids $1.38 Billion for Alpharma
Bloomberg
Friday, August 22, 2008 - 9:30am
tags:

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Down There in the Nano-Flow
In the Pipeline
Large Chains’ Position in 2025’s Part D Pharmacy Networks: Supermarkets Take the Lead in a Shrinking PDP Market
Drug Channels
CNS Drug Development: Same As It Ever Was
In the Pipeline
From Integration to AI: The Data-Driven Future of Market Access
Drug Channels
On RFK Jr. And What We're In For
In the Pipeline
Natural-Ish Product Motifs
In the Pipeline
Medicare Part D in 2025: Preferred Pharmacy Networks Fade in a Collapsing PDP Market
Drug Channels
Deuterium In Court
In the Pipeline
Drug Channels Outlook 2025 (NEW Live Video Webinar)
Drug Channels

Latest Jobs

Area Manager, Specialty Southeast
Fields, Oregon, 97710
CSL Behring
Neuroscience Account Manager - Milwaukee, WI
Milwaukee, Wisconsin, US
Lundbeck
BioPharmaceutical Account Manager - Houston South, TX
Houston, Texas, US
Lundbeck
Associate Director, Strategic Account Management -Pacific
San Francisco, California
AbbVie
Senior Director, US HIV Prevention Launch Hub Lead
Foster City, California
Gilead Sciences, Inc.
Therapy Development Manager Transcatheter Heart Valve
San Diego, California, 92189
Edwards Lifesciences
Neuroscience Account Manager (Psychiatry) - Missoula, MT
Missoula, Montana, 59812
Vanda Pharmaceuticals
Senior Account Manager IV Therapy - Northern CA / Nevada
Honolulu, Hawaii, 96814
Fresenius Kabi USA, LLC
Psychiatry Account Manager - Dayton West, OH
Oakwood, Ohio, 45873
Lundbeck
Neuroscience Account Manager (Psychiatry) - Detroit East, MI
Hamtramck, Michigan, 48212
Vanda Pharmaceuticals
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information